A new collaboration has developed in the world of biological seed treatments. On Sept. 16, Syngenta Crop Protection’s Seedcare business and Bioceres Crop Solutions announced a global commercial and R&D partnership. This collaboration builds “on a successful commercial partnership of more than 20 years in Argentina,” a release says.
With the agreement, Syngenta Seedcare will become the exclusive commercialization distributor for Bioceres biological seed treatment solutions — specifically, their line of biological inoculants, including their rhizobia bacteria strain. Bioceres will continue to collaborate in Argentina under their existing framework.
This collaboration will allow the companies “to jointly undertake the development of new products while accelerating the registration of products already in the pipeline.”
“The agreement with Bioceres furthers our strategy to provide growers with more complementary choices to manage pest resistance and improve crop health,” Jonathan Brown, Global Head of Syngenta Seedcare, said in the release. “We draw strengths from our longstanding relationship with Bioceres and are fully committed to providing growers with more sustainable innovations to further improve seed health.”
“This announcement shows the value of our commercial offerings and R&D capabilities, and greatly expands and accelerates our ability to reach more growers through the global reach of Syngenta Seedcare,” said Federico Trucco, CEO of Bioceres, in the release. “Biological products play an important role in offering growers new solutions to increase crop yields while reducing agriculture’s environmental footprint. We believe this collaboration with Syngenta will allow us both to advance those goals more rapidly in a time of significant global need for new solutions.”
